NCT06707025View on ClinicalTrials.gov

"The Expression of CD24 do-not-eat-me Signal in Cholangiocarcinoma"

Active, not recruitingOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

November 10, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

October 28, 2026

Conditions

Cholangiocarcinoma

Trial Locations (1)

9112001

Hdassah Hospital, Jerusalem

All Listed Sponsors

lead

Hadassah Medical Organization

OTHER